Related Experiment Video
Updated: May 24, 2026
10:48
Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
In vitro characterization of a nineteenth-century therapy for smallpox
William Arndt1, Chandra Mitnik, Karen L Denzler
1Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.
Plos One
|March 20, 2012
Summary
The carnivorous plant Sarracenia purpurea extract inhibits poxvirus replication by targeting early viral transcription. This botanical preparation shows potential as a novel antiviral defense against Orthopoxvirus infections.
Area of Science:
- Virology
- Ethnobotany
- Natural Product Chemistry
Background:
- Smallpox historically caused devastating epidemics in North America.
- A 19th-century botanical remedy from Sarracenia purpurea was reputedly used to treat smallpox.
- Poxvirus infections remain a public health concern, necessitating new therapeutic strategies.
Observation:
- The study investigated the antiviral properties of a Sarracenia purpurea botanical extract.
- The extract's activity was tested against vaccinia virus, monkeypox virus, and variola virus.
- Sarracenia purpurea was evaluated for its potential to inhibit poxvirus replication.
Findings:
- Sarracenia purpurea extract demonstrated in vitro antipoxvirus activity.
- This botanical preparation is the first identified inhibitor of poxvirus replication at the early transcription stage.
- The extract effectively inhibited the replication of vaccinia, monkeypox, and variola viruses.
Implications:
- Sarracenia purpurea represents a novel therapeutic candidate for poxvirus infections.
- The findings suggest a potential natural product-based defense against Orthopoxvirus outbreaks.
- This research validates historical ethnobotanical uses with modern scientific investigation.
